Since abnormal K-Ras activation and the associated mitochondrial dysfunction and metabolic shift are frequently observed in human cancer, the use of the current experimental system enabled us to identify a key molecular player that seems essential to maintain the metabolic changes in K-Ras-transformed cells. This evidence concerns the gene KRAS and cancer.